USU will develop technology for manufacturing radiopharmaceuticals

| By | Drug Development, R&D, Radiopharmaceuticals

A center for personalized nuclear medicine was opened on the basis of the Ulyanovsk State University (USU).

The new center will ensure the development of technology for manufacturing the radiopharmaceuticals, their further use, pilot manufacturing, preclinical testing, clinical trials, and the transfer of technology for the synthesis of these drugs to nuclear medicine markets, both in Russia and abroad. As a result, the Ulyanovsk region will create a new sector of its economy helping to reduce mortality from oncological diseases, to expand R&D, and establish new high-tech jobs.

“We hope that, in the near future, the research conducted in the labs will be used by our medical institutions, and the patients will receive treatment with the new fourth generation radiopharmaceuticals. As a result, the establishment of this science and technology center at the Ulyanovsk State University will enable us to implement more effectively the tasks set by the May 2012 Decrees of the Russian President in order to increase the life expectancy and reduce mortality of the population,” said the Governor of the Ulyanovsk region Sergey Morozov.